Eiger BioPharmaceuticals Inc. (EIGR) Dropped -5.71% or -0.64 To Price $10.49 On Tuesday


Eiger BioPharmaceuticals Inc. (EIGR) dropped -5.71% or -0.64 to $10.49. It is near 146949 shares traded, which is 128.34% compare to the average total volume 114501. The market cap of EIGR is $200.41 million. The year to date change is -26.49%. The 52 week price range is from $7.46 to $18.0. Price of EIGR have changed -0.54% during last week. It have changed 25.76% over last month, -4.87% over last 3 months, -22.71% over last 6 months and -6.47% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 10.87. It is 3.62% above current price. The 200-day Moving Averages for EIGR is 11.23. It is 7.05% above current price. The 52-week High is 18.0. It is 71.59% from the current price. The 52-week Low is 7.46. It is -28.88% from current price.

There are some statistics of EIGR. It is has market cap $200.41 million. The share outstanding is 19.10 million. The average volume is 114501. The percent of top 15 Institution holding is 63.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -201.99%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -92.95%.


Tags:

Share this post